Nephrology

Latest News

Daily Dose: COVID-19, Opioid Epidemic Primary Drivers of Widening Gender Gap in Life Expectancy / image credit: ©New Africa/AdobeStock
Daily Dose: COVID-19, Opioid Epidemic Primary Drivers of Widening Gender Gap in Life Expectancy

November 29th 2023

Your daily dose of the clinical news you may have missed.

New CVD Risk Equations are Sex-Specific, Exclude Race, Include eGFR, and Predict Heart Failure / image credit  heart/kidney/pancreas©Fandorina Liza/stock.adobe.com
New CVD Risk Equations are Sex-Specific, Exclude Race, Include eGFR, and Predict Heart Failure

November 20th 2023

One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults
One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults

September 29th 2023

Empagliflozin Wins FDA Approval for the Treatment of Adults with CKD / Image credit: ©Olivier Le Moal/AdobeStock
Empagliflozin Wins FDA Approval for the Treatment of Adults with CKD

September 22nd 2023

image credit pills money ©alex mlx/stock.adobe.com
Biden Administration Announces First 10 Prescription Drugs Slated for Price Negotiations

August 29th 2023

Latest CME Events & Activities

Expert Illustrations & Commentaries™: Emerging Strategies for the Treatment of Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Clinical ShowCase™ in aHUS: The Application of Complement Inhibitors in Practice

View More

Transfusion-Related Iron Overload–Evidence-Based Approaches to Improve Chelation Outcomes

View More

GU Tumor Board®: Real World Strategies to Inform Individualized Care in Renal Cell Carcinoma

January 25, 2024

Register Now!

Community Practice Connections™: Visualizing New Treatment Pathways for Anemia in Chronic Kidney Disease

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Collaborating Across the Continuum™: Taking IgA Nephropathy Management to the Next Level

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

March 8-9, 2024

Register Now!

New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities

View More

Expert Illustrations and Commentaries™: Emerging Therapies and Treatment Strategies to Improve Care for Your Patients with Anemia in CKD

View More

The Nephrology Nurse’s Role in Optimizing Outcomes for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?

View More

Community Practice Connections: 7th Annual School of Nursing Oncology™

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?

View More

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2023 MJH Life Sciences

All rights reserved.